Innate Immunity and Epithelial Biology: Special Considerations in the Neonatal Gut

Neonatology: Questions and Controversies Series Gastroenterology and Nutrition

Volumn , Issue , 2008, Pages 51-72

  Lin, Patricia W ^a   Neish, Andrew S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942598194     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3160-4.10004-5     Document Type: Chapter

References (140)

1. Madara JL Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 1990, 137(6):1273-1281.
2. Xu J, Gordon JI Inaugural Article: Honor thy symbionts. Proc Natl Acad Sci USA 2003, 100(18):10452-10459.
3. Hooper LV, Gordon JI Commensal host-bacterial relationships in the gut. Science 2001, 292(5519):1115-1118.
4. Pinto D, Clevers H Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 2005, 306(2):357-363.
5. Nusrat A, Turner JR, Madara JL Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000, 279(5):G851-G857.
6. Hecht G Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol 1999, 277(3 Pt 1):C351-C358.
7. Otte JM, Kiehne K, Herzig KH Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 2003, 38(8):717-726.
8. Scott MG, Hancock RE Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000, 20(5):407-431.
9. Ganz T Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3(9):710-720.
10. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999, 286(5437):113-117.
11. Ghosh D, Porter E, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002, 3(6):583-590.
12. Ayabe T, Satchell DP, Wilson CL, et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000, 1(2):113-118.
13. Eckmann L Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 2004, 20(2):82-88.
14. O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999, 163(12):6718-6724.
15. Huttner KM, Bevins CL Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999, 45(6):785-794.
16. Cociancich S, Ghazi A, Hetru C, et al. Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J Biol Chem 1993, 268(26):19239-19245.
17. Kagan BL, Selsted ME, Ganz T, et al. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990, 87(1):210-214.
18. Lehrer RI, Ganz T, Selsted ME Defensins: endogenous antibiotic peptides of animal cells. Cell 1991, 64(2):229-230.
19. Lehrer RI, Barton A, Daher KA, et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989, 84(2):553-561.
20. Ouellette AJ Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin Immunopathol 2005, 27(2):133-146.
21. Chen H, Xu Z, Peng L, et al. Recent advances in the research and development of human defensins. Peptides 2006, 27(4):931-940.
22. Eckmann L Defence molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 2005, 21(2):147-151.
23. Lencer WI, Cheung G, Strohmeier GR, et al. Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci USA 1997, 94(16):8585-8589.
24. Merlin D, Yue G, Lencer WI, et al. Cryptdin-3 induces novel apical conductance(s) in Cl-secretory, including cystic fibrosis, epithelia. Am J Physiol Cell Physiol 2001, 280(2):C296-C302.
25. Lin PW, Simon PO, Gewirtz AT, et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 2004, 279(19):19902-19907.
26. Kim DH, Feinbaum R, Alloing G, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002, 297(5581):623-626.
27. Asai T, Tena G, Plotnikova J, et al. MAP kinase signalling cascade in Arabidopsis innate immunity. Nature 2002, 415(6875):977-983.
28. Barton GM, Medzhitov R Toll-like receptors and their ligands. eds. Toll-like receptor family members and their ligands 2002, 81-92. Springer, New York. B. Beutler, H. Wagner (Eds.).
29. Cario E, Brown D, McKee M, et al. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 2002, 160(1):165-173.
30. Gordon S Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111(7):927-930.
31. Takeda K, Kaisho T, Akira S Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
32. O'Neill LAJ Signal transduction pathways activated by the IL-1 receptor/Toll-like receptor superfamily. eds. Toll-like receptor family members and their ligands 2002, 47-62. Springer, New York. B. Beutler, H. Wagner (Eds.).
33. Gewirtz AT, Navas TA, Lyons S, et al. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001, 167(4):1882-1885.
34. Hornef MW, Frisan T, Vandewalle A, et al. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002, 195(5):559-570.
35. Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5(6):446-458.
36. Girardin SE, Tournebize R, Mavris M, et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2001, 2(8):736-742.
37. Inohara N, Nunez G NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003, 3(5):371-382.
38. Silverman N, Maniatis T NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001, 15(18):2321-2342.
39. Jobin C, Sartor RB The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 2000, 278(3):C451-C462.
40. O'Neill LA, Fitzgerald KA, Bowie AG The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003, 24(6):286-290.
41. Kopp E, Medzhitov R Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003, 15(4):396-401.
42. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003, 424(6950):743-748.
43. Picard C, Puel A, Bonnet M, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299(5615):2076-2079.
44. Deng L, Wang C, Spencer E, et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103(2):351-361.
45. Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001, 412(6844):346-351.
46. Ben-Neriah Y Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002, 3(1):20-26.
47. May MJ, Ghosh S IkappaB kinases: kinsmen with different crafts. Science 1999, 284(5412):271-273.
48. Karin M, Ben-Neriah Y Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663.
49. Inohara N, Koseki T, del Peso L, et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 1999, 274(21):14560-14567.
50. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416(6877):194-199.
51. Gewirtz AT, Rao AS, Simon PO, et al. Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated activation of the NF-kappaB pathway. J Clin Invest 2000, 105(1):79-92.
52. Winston JT, Strack P, Beer-Romero P, et al. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 1999, 13(3):270-283.
53. Spencer E, Jiang J, Chen ZJ Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev 1999, 13(3):284-294.
54. Read MA, Brownell JE, Gladysheva TB, et al. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol 2000, 20(7):2326-2333.
55. Chen LW, Egan L, Li ZW, et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003, 9(5):575-581.
56. Read MA, Neish AS, Luscinskas FW, et al. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995, 2(5):493-506.
57. Jobin C, Panja A, Hellerbrand C, et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol 1998, 160(1):410-418.
58. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289(5484):1560-1563.
59. Collier-Hyams LS, Sloane V, Batten BC, et al. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol 2005, 175(7):4194-4198.
60. Elewaut D, DiDonato JA, Kim JM, et al. NF-[kappa]B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. Journal of Immunology 1999, 163(3):1457-1466.
61. Chang L, Karin M Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824):37-40.
62. Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001, 19:623-655.
63. Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17(3):251-263.
64. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003, 4(5):491-496.
65. Sharma S, tenOever BR, Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300(5622):1148-1151.
66. Boldrick JC, Alizadeh AA, Diehn M, et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA 2002, 99(2):972-977.
67. Eckmann L, Smith JR, Housley MP, et al. Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria Salmonella. J Biol Chem 2000, 275(19):14084-14094.
68. Zeng H, Carlson AQ, Guo Y, et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 2003, 171(7):3668-3674.
69. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J 1995, 9(10):899-909.
70. Conlan JW Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect Immun 1997, 65(2):630-635.
71. Nau GJ, Richmond JF, Schlesinger A, et al. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 2002, 99(3):1503-1508.
72. Adams JM Ways of dying: multiple pathways to apoptosis. Genes Dev 2003, 17(20):2481-2495.
73. Meier P, Finch A, Evan G Apoptosis in development. Nature 2000, 407(6805):796-801.
74. Green DR, Kroemer G The pathophysiology of mitochondrial cell death. Science 2004, 305(5684):626-629.
75. Yeh WC, Pompa JL, McCurrach ME, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279(5358):1954-1958.
76. Karin M, Lin A NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3(3):221-227.
77. Collier-Hyams LS, Neish AS Innate immune relationship between commensal flora and the mammalian intestinal epithelium. Cell Mol Life Sci 2005, 62(12):1339-1348.
78. Zeng H, Wu H, Sloane V, et al. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol 2006, 290(1):G96-G108.
79. Beg AA, Baltimore D An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274(5288):782-784.
80. Chen Z, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 1995, 9(13):1586-1597.
81. Dispenzieri A Bortezomib for myeloma - much ado about something. N Engl J Med 2005, 352(24):2546-2548.
82. Rumbo M, Schiffrin EJ Ontogeny of intestinal epithelium immune functions: developmental and environmental regulation. Cell Mol Life Sci 2005, 62(12):1288-1296.
83. Polak-Charcon S, Shoham J, Ben-Shaul Y Tight junctions in epithelial cells of human fetal hindgut, normal colon, and colon adenocarcinoma. J Natl Cancer Inst 1980, 65(1):53-62.
84. Lebenthal A, Lebenthal E The ontogeny of the small intestinal epithelium. JPEN J Parenter Enteral Nutr 1999, 23(5 Suppl):S3-S6.
85. Buisine MP, Devisme L, Savidge TC, et al. Mucin gene expression in human embryonic and fetal intestine. Gut 1998, 43(4):519-524.
86. Mallow EB, Harris A, Salzman N, et al. Human enteric defensins. Gene structure and developmental expression. J Biol Chem 1996, 271(8):4038-4045.
87. Newell SJ Enteral feeding of the micropremie. Clin Perinatol 2000, 27(1):221-234. viii.
88. Logan CY, Nusse R The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
89. Reya T, Clevers H Wnt signalling in stem cells and cancer. Nature 2005, 434(7035):843-850.
90. Moon RT, Kohn AD, De Ferrari GV, et al. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 2004, 5(9):691-701.
91. Ohnaka K, Taniguchi H, Kawate H, et al. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 2004, 318(1):259-264.
92. Ouellette AJ, Greco RM, James M, et al. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol 1989, 108(5):1687-1695.
93. Salzman NH, Polin RA, Harris MC, et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998, 44(1):20-26.
94. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307(5710):731-734.
95. Ahrens P, Kattner E, Kohler B, et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr 2004, 55(4):652-656.
96. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603.
97. Habib Z, Arnaud B, de Pascal L, et al. CARD15/NOD2 is not a predisposing factor for necrotizing enterocolitis. Dig Dis Sci 2005, 50(9):1684-1687.
98. Fusunyan RD, Nanthakumar NN, Baldeon ME, et al. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 2001, 49(4):589-593.
99. Nanthakumar NN, Fusunyan RD, Sanderson I et al. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000, 97(11):6043-6048.
100. Claud EC, Lu L, Anton PM, et al. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004, 101(19):7404-7408.
101. Sepkowitz KA Gastrointestinal infections in neutropenic patients. et al., eds. Infections of the gastrointestinal tract 2002, 473-479. Lippincott, Philadelphia. M.J. Blaser (Ed.).
102. Takeuchi O, Hoshino K, Akira S Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165(10):5392-5396.
103. Sha WC, Liou H-C, Tuomanen EI, et al. Targeted disruption of the p50 subunit of NF-[kappa]B leads to multifocal defects in immune responses. Cell 1995, 80(2):321-330.
104. Russo MP, Boudreau F, Li F, et al. NF-kB blockade exacerbates experimental colitis in transgenic mice expression an intestinal epithelial cell specific IkB super-repressor (abst). Gastroenterology 2001, 120.
105. Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004, 55(4):622-629.
106. Pacha J Development of intestinal transport function in mammals. Physiol Rev 2000, 80(4):1633-1667.
107. McClure RJ Trophic feeding of the preterm infant. Acta Paediatr Suppl 2001, 90(436):19-21.
108. Hooper LV Bacterial contributions to mammalian gut development. Trends Microbiol 2004, 12(3):129-134.
109. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291(5505):881-884.
110. Falk PG, Hooper LV, Midtvedt T, et al. Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62(4):1157-1170.
111. McCracken VJ, Lorenz RG The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001, 3(1):1-11.
112. Hoy CM, Wood CM, Hawkey PM, et al. Duodenal microflora in very-low-birth-weight neonates and relation to necrotizing enterocolitis. J Clin Microbiol 2000, 38(12):4539-4547.
113. de la Cochetiere MF, Piloquet H, des Robert C, et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 2004, 56(3):366-370.
114. Schumann A, Nutten S, Donnicola D, et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005, 23(2):235-245.
115. Wallace TD, Bradley S, Buckley ND, et al. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 2003, 66(3):466-472.
116. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999, 116(5):1107-1114.
117. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004, 5(1):104-112.
118. Bourlioux P, Koletzko B, Guarner F, et al. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium 'The Intelligent Intestine', held in Paris, June 14 2002. Am J Clin Nutr 2003, 78(4):675-683.
119. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005, 115(1):1-4.
120. Kliegman RM, Willoughby RE Prevention of necrotizing enterocolitis with probiotics. Pediatrics 2005, 115(1):171-172.
121. Teitelbaum JE, Walker WA Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 2002, 22:107-138.
122. Mack DR, Lebel S Role of probiotics in the modulation of intestinal infections and inflammation. Curr Opin Gastroenterol 2004, 20(1):22-26.
123. Sartor RB Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126(6):1620-1633.
124. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(2):229-241.
125. Ouwehand AC, Derrien M, de Vos W, et al. Prebiotics and other microbial substrates for gut functionality. Curr Opin Biotechnol 2005, 16(2):212-217.
126. Knol J, Boehm G, Lidestri M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr Suppl 2005, 94(449):31-33.
127. Boehm G, Stahl B, Jelinek J, et al. Prebiotic carbohydrates in human milk and formulas. Acta Paediatr Suppl 2005, 94(449):18-21.
128. Fanaro S, Boehm G, Garssen J, et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr Suppl 2005, 94(449):22-26.
129. Tsukahara T, Iwasaki Y, Nakayama K, et al. Stimulation of butyrate production in the large intestine of weaning piglets by dietary fructooligosaccharides and its influence on the histological variables of the large intestinal mucosa. J Nutr Sci Vitaminol (Tokyo) 2003, 49(6):414-421.
130. Bartholome AL, Albin DM, Baker DH, et al. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr 2004, 28(4):210-222. discussion 222-223.
131. Kanauchi O, Andoh A, Iwanaga T, et al. Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model. J Gastroenterol Hepatol 1999, 14(12):1173-1179.
132. Yin L, Laevsky G, Giardina C Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 2001, 276(48):44641-44646.
133. Venkatraman A, Ramakrishna BS, Shaji RV, et al. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 2003, 285(1):G177-G184.
134. Avivi-Green C, Polak-Charcon S, Madar Z, et al. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res 2000, 12(2):83-95.
135. Mentschel J, Claus R Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment. Metabolism 2003, 52(11):1400-1405.
136. Scheppach W, Weiler F The butyrate story: old wine in new bottles?. Curr Opin Clin Nutr Metab Care 2004, 7(5):563-567.
137. Strober W Epithelial cells pay a Toll for protection. Nat Med 2004, 10(9):898-900.
138. Abreu MT, Vora P, Faure E, et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001, 167(3):1609-1616.
139. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126(2):520-528.
140. Francois S, El Benna J, Dang PM, et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J Immunol 2005, 174(6):3633-3642.